Science Corporation Unicorn Score: 82/100
Alameda, United StatesScience Corporation is a clinical-stage medical technology company focused on neural engineering solutions. The company develops advanced medical technologies to restore vision, cognition, and mobility for patients with debilitating conditions lacking treatment options. Additionally, Science Corporation provides state-of-the-art components and vertically integrated infrastructure through Science Foundry to support broader industry progress.
Valuation track record
- First screened
- Aug 4, 2026
- Entry valuation
- $1.5B
- Current valuation
- $1.5B
Latest valuation verified from Live re-screening on Aug 4, 2026. Updated quarterly from public funding announcements.
Founders
Max Hodak
Founder and CEO
Alan Mardinly
Co-founder, Chief Scientific Officer
Yifan Kong
Co-founder
Get the full Science Corporation report
Founders deep-dive, traction signals, market thesis, red flags, scoring breakdown and an audio summary, delivered to your inbox.
Frequently asked
What is Science Corporation's unicorn score?
Science Corporation has a Unicorn Screener score of 82/100, classified as "High Potential". Recommended action: buy.
What is Science Corporation's current valuation?
Science Corporation's most recently verified valuation is $1.5B, last checked on Aug 4, 2026 (source: Live re-screening).
What sector is Science Corporation in?
Science Corporation operates in the HealthTech sector and is headquartered in Alameda, United States.
When was Science Corporation first screened?
Science Corporation was first screened by Unicorn Screener on Aug 4, 2026, with an entry valuation of $1.5B.